| | methyprylon Basic information |
| Product Name: | methyprylon | | Synonyms: | Methyprylone;2,4-Piperidinedione, 3,3-diethyl-5-methyl-;(+)-Noludar;Ro-1-6463;3,3-diethyl-5-methyl-piperidine-2,4-quinone;2,4-Dioxo-3,3-diethyl-5-methylpiperidine;Nodular;NSC 30442 | | CAS: | 125-64-4 | | MF: | C10H17NO2 | | MW: | 183.25 | | EINECS: | 204-745-4 | | Product Categories: | | | Mol File: | 125-64-4.mol |  |
| | methyprylon Chemical Properties |
| Melting point | 74-77° | | Boiling point | 316.93°C (rough estimate) | | density | 1.0612 (rough estimate) | | refractive index | 1.4730 (estimate) | | solubility | Chloroform: soluble; Ethanol: soluble | | form | A crystalline solid | | pka | 12.11±0.70(Predicted) | | Water Solubility | 76g/L(25 ºC) | | EPA Substance Registry System | 2,4-Piperidinedione, 3,3-diethyl-5-methyl- (125-64-4) |
| | methyprylon Usage And Synthesis |
| Chemical Properties | Nearly white, crystalline powder; slightcharacteristic odor; bitter taste. Melting range 74–77C. Soluble in water; very soluble in alcohol, chlo-roform, ether, and benzene. | | Originator | Noludar,Roche,US,1955 | | Uses | Medicine (sedative, hypnotic). | | Definition | ChEBI: Methyprylon is an organic molecular entity. | | Manufacturing Process | 24 parts by weight of powdered sodium are suspended in 100 parts by
volume of absolute benzene and to this suspension is added a freshly
prepared solution of 150 parts by weight of methyl formate and 165 parts by
weight of 2,4-dioxo-3,3-diethyl-piperidine in 900 parts by volume of absolute
benzene. By cooling with cold water, the temperature is maintained at 25° to
28°C. After being stirred for 12 hours 200 parts by volume of 0.6 N sodium
hydroxide are added while cooling. The aqueous layer is separated and
acidified to Congo red by means of 35% hydrochloric acid. The 2,4-dioxo-3,3-
diethyl-5-oxymethylenepiperidine is precipitated in good yield as a solid. After
having been recrystallized in chloroform/petroleum ether it melts at 140° to 141°C.
5 parts by weight of 2,4-dioxo-3,3-diethyl-5-oxymethylene-piperidine are
hydrogenated in 25 parts by volume of methanol in the presence of about 2
parts by weight of Raney nickel at 120°C and under an elevated pressure of
100 atm. Once 2 mols of hydrogen are absorbed, the hydrogenation is
interrupted, the solution is separated from the catalyst and concentrated and
the residue is distilled in vacuo. The distillate, boiling between 178° and
185°C under a pressure of 16 mm, consists of 2,4-dioxo-3,3-diethyl-5-methylpiperidine, which melts at 74° to 75°C.
The same compound is obtained when proceeding according to the following
alternative procedure. A mixture of 39.4 parts by weight of 2,4-dioxo-3,3-
diethyl-5-oxymethylenepiperidine and 27 parts by weight of dibutylamine are
heated to 150°C in a closed vessel. The 2,4-dioxo-3,3-diethyl-5-dibutylaminomethylene-piperidine formed melts at 77°C after having been recrystallized in
petroleum ether.
31 parts by weight of the latter compound are hydrogenated in 150 parts by
volume of alcohol, containing 6 parts by weight of acetic acid, in the presence
of 10 parts by weight of Raney nickel, at 120°C and under an elevated
pressure of 100 atm. The catalyst is separated and the solution is distilled in
vacuo. The 2,4-dioxo-3,3-diethyl-5-methyl-piperidine boils between 178° and
185°C under a pressure of 16 mm and melts at 74° to 75°C. | | Brand name | Nolurate. | | Therapeutic Function | Sedative, Hypnotic | | World Health Organization (WHO) | Methyprylon, a piperidine derivative, was introduced in 1955 for
use as a sedative-hypnotic drug. Habituation, tolerance, physical dependence and
addiction can occur and methyprylon is controlled under Schedule IV of the 1971
Convention on Psychotropic Substances.
(Reference: (UNCPS4) United Nations Convention on Psychotropic Substances (IV),
, , 1971) | | Hazard | Abuse may cause addiction. |
| | methyprylon Preparation Products And Raw materials |
|